Abstract:The aim of this study was to investigate prevalences of hyperuricemia and the metabolic syndrome (MS) in the Hangzhou population, and the relationship between serum uric acid and the MS. A cross-sectional study was conducted among 4155 subjects (2614 men and 1541 women) aged 20-80 years, recruited through a health check program in Hangzhou, China. Biochemical and haematological parameters were measured by standard methods. The diagnosis of the MS is made when three or four of the following criteria are met: 1) body mess index (BMI) >= 25; 2) systolic blood pressure >= 140 mmHg or diastolic blood pressure >= 25; 2) systolic blood pressure >= 140 mmHg or diastolic blood pressure > 90 mmHg; 3) fasting triacyglycerol >= 90 mmHg; 3) fasting triacyglycerol > 1.7 mmol/L (150 mg/dL), high density lipoprotein cholesterol (HDL-C) < 0.9 mmol/L (35 mg/dL) in men and <1.0 mmol/L (39 mg/dL) in women; 4) fasting glucose >= 6.1 mmol/L (109 mg/dL). Hyperuricemia is defined by cut-off values of >420 mu mol/L for men and > 360 mu mol/L for women. Prevalences were 16.9% (N=702) for hyperuricemia and 8.4% (N=349) for the MS. Serum uric acid concentration was significantly higher in mates than in females (p<0.0001), and significantly higher in subjects with obesity, dyslipidemia and hypertension compared with those without. In the partial correlation analysis, after controlling for gender, age and creatinine, serum uric acid concentration was significantly positively correlated with BMI (r=0.301, p<0.0001), systolic blood pressure (r=0.151, p<0.0001), diastolic blood pressure (r=0.168, p<0.0001), total cholesterol (r=0.144, p<0.0001) and triacyglycerol (r=0.234, p<0.0001). Results suggest that increased serum uric acid concentration is associated with an increased prevalence of metabolic disorders such as obesity, dyslipidemia and hypertension in the Hangzhou population.

The Relationship Between Hyperuricemia and the Components of Metabolic Syndrome and Their Nutritional Treatment

Relationship Between Hyperuricemia and Metabolic Syndrome.

The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies

Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases

The relationship between hyperuricemia and senile diseases

Hyperuricemia and Kidney Diseases

Hyperuricemia and the metabolic syndrome in Hangzhou | Chinese Source

Hyperuricemia and its related diseases: mechanisms and advances in therapy

Hyperuricemia and the metabolic syndrome in Hangzhou.

Hyperuricemia research progress in model construction and traditional Chinese medicine interventions

Hyperuricemia prevalence and its association with metabolic disorders: a multicenter retrospective real-world study in China

The role of diet in gout and hyperuricemia

Clinical Value Of Serum Lipid Profile And Renal Function For The Management Of Hyperuricemia In Adults In Southern China

Hyperuricemia: A key contributor to endothelial dysfunction in cardiovascular diseases

Urinary Proteomic Characteristics of Hyperuricemia and Their Possible Links with the Occurrence of Its Concomitant Diseases

Clinical study on the correlation between serum uric acid and other metabolic indexes

The Role of Hyperuricemia in Cardiac Diseases: Evidence, Controversies, and Therapeutic Strategies

Association Between Different Metabolic Markers and Metabolic Syndrome in an Outpatient Hyperuricemia Population: A Cross-Sectional Study

[Modern understanding of uric acid metabolism disorders and progress in traditional Chinese medicine prevention and treatment]

Effects of smoking, drinking and dietary factors on hypertension in subjects with hyperuricemia

Relationship between serum uric acid and levels of HGPRT and VitC in serum in hyperuricemia patients